A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 8, 2012, Pages 1362-1370

  Ding, Yuan C ^a   McGuffog, Lesley ^b   Healey, Sue ^d   Friedman, Eitan ^e,cz   Laitman, Yael ^e,da   Shimon, Shani Paluch ^e,da   Kaufman, Bella ^e,da   Liljegren, Annelie ^f   Lindblom, Annika ^f   Olsson, Håkan ^g   Kristoffersson, Ulf ^g   Stenmark Askmalm, Marie ^h   Melin, Beatrice ⁱ   Domchek, Susan M ^j   Nathanson, Katherine L ^j   Rebbeck, Timothy R ^j   Jakubowska, Anna ^l   Lubinski, Jan ^l   Jaworska, Katarzyna ^l   Durda, Katarzyna ^l   Gronwald, Jacek ^l   Huzarski, Tomasz ^l   Cybulski, Cezary ^l   Byrski, Tomasz ^l   Osorio, Ana ^m,n   Cajal, Teresa Ramóny ⁿ   Stavropoulou, Alexandra V ^p   Benítez, Javier ^m,n   Hamann, Ute ^q   Rookus, Matti ^r   Aalfs, Cora M ^s   De Lange, Judith L ^r   Meijers Heijboer, Hanne E J ^t   Oosterwijk, Jan C ^ct   Van Asperen, Christi J ^cu   Gómez García, Encarna B ^cv   Hoogerbrugge, Nicoline ^cw   Jager, Agnes ^cx   Van Der Luijt, Rob B ^cy   Easton, Douglas F ^c   Peock, Susan ^c   Frost, Debra ^c   Ellis, Steve D ^c   Platte, Radka ^c   Fineberg, Elena ^c   Evans, D Gareth ^u   Lalloo, Fiona ^u   Izatt, Louise ^v   Eeles, Ros ^w   Adlard, Julian ^x   Davidson, Rosemarie ^y   Eccles, Diana ^z   Cole, Trevor ^aa   Cook, Jackie ^ab   Brewer, Carole ^ac   Tischkowitz, Marc ^c   Godwin, Andrew K ^ad   Pathak, Harsh ^ad   Stoppa Lyonnet, Dominique ^ae,af,ag   Sinilnikova, Olga M ^aj,ak   Mazoyer, Sylvie ^aj   Barjhoux, Laure ^aj   Léoné, Mélanie ^ak   Gauthier Villars, Marion ^ae   Caux Moncoutier, Virginie ^ae   De Pauw, Antoine ^ae   Hardouin, Agnés ^an   Berthet, Pascaline ^an   Dreyfus, Héléne ^ah,ai   Ferrer, Sandra Fert ^bb   Collonge Rame, Marie Agnés ^al   Sokolowska, Johanna ^am   Buys, Saundra ^ao   Daly, Mary ^k   Miron, Alex ^ap   Terry, Mary Beth ^at   Chung, Wendy ^at   John, Esther M ^au,db   Southey, Melissa ^av   Goldgar, David ^ao   Singer, Christian F ^aw   Tea, Muy Kheng Maria ^aw   Gschwantler Kaulich, Daphne ^aw   Fink Retter, Anneliese ^aw   Hansen, Thomas V O ^ax   Ejlertsen, Bent ^ax   Johannsson, Oskar T ^ay,dc   Offi, Kenneth ^az   Sarrel, Kara ^az   Gaudet, Mia M ^ba   Vijai, Joseph ^az   Robson, Mark ^az   Piedmonte, Marion R ^az   Andrews, Lesley ^bc   Cohn, David ^bd   DeMars, Leslie R ^bf   DiSilvestro, Paul ^bg   Rodriguez, Gustavo ^bh   Toland, Amanda Ewart ^be   Montagna, Marco ^bi   Agata, Simona ^bi   Imyanitov, Evgeny ^bj   Isaacs, Claudine ^bk   Janavicius, Ramunas ^bl,bm   Lazaro, Conxi ^o   Blanco, Ignacio ^o   Ramus, Susan J ^bn   Sucheston, Lara ^az   Karlan, Beth Y ^bo   Gross, Jenny ^bo   Ganz, Patricia A ^bp   Beattie, Mary S ^bq   Schmutzler, Rita K ^br   Wappenschmidt, Barbara ^br   Meindl, Alfons ^bs   Arnold, Norbert ^bt   Niederacher, Dieter ^bu   Preisler Adams, Sabine ^bv   Gadzicki, Dorotehea ^bw   Varon Mateeva, Raymonda ^bx   Deissler, Helmut ^by   Gehrig, Andrea ^bz   Sutter, Christian ^ca   Kast, Karin ^cb   Nevanlinna, Heli ^cc   Aittomäki, Kristiina ^cc   Simard, Jacques ^cd   Spurdle, Amanda B ^d   Beesley, Jonathan ^d   Chen, Xiaoqing ^d   Tomlinson, Gail E ^ce   Weitzel, Jeffrey ^a   Garber, Judy E ^aq   Olopade, Olufunmilayo I ^cf   Rubinstein, Wendy S ^bh   Tung, Nadine ^ar   Blum, Joanne L ^cg   Narod, Steven A ^ch   Brummel, Sean ^as   Gillen, Daniel L ^ck   Lindor, Noralane ^cl   Fredericksen, Zachary ^cl   Pankratz, Vernon S ^cl   Couch, Fergus J ^cl   Radice, Paolo ^cn   Peterlongo, Paolo ^cm,cn   Greene, Mark H ^co   Loud, Jennifer T ^co   Mai, Phuong L ^co   Andrulis, Irene L ^ci,cj   Glendon, Gord ^ci   Ozcelik, Hilmi ^ci,cj   Gerdes, Anne Marie ^ax   Thomassen, Mads ^cp   Jensen, Uffe Birk ^cq   Skytte, Anne Bine ^cr   Caligo, Maria A ^cs   Lee, Andrew ^b   Chenevix Trench, Georgia ^d   Antoniou, Antonis C ^b   Neuhausen, Susan L ^a   more..

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e SHEBA MEDICAL CENTER   (Israel)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h LINKÖPING UNIVERSITY   (Sweden)

ⁱ UMEÅ UNIVERSITY   (Sweden)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k FOX CHASE CANCER CENTER   (United States)

^l POMERANIAN MEDICAL UNIVERSITY   (Poland)

^m Centro Nacional de Investigaciones Oncológicas   (Spain)

ⁿ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^o CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^p INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^q GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^r NETHERLANDS CANCER INSTITUTE   (Netherlands)

^s ACADEMIC MEDICAL CENTER   (Netherlands)

^t VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^u UNIVERSITY OF MANCHESTER   (United Kingdom)

^v GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^w INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^x Yorkshire Regional Genetics Service   (United Kingdom)

^y ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^z UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^aa BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^ab SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^ac ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^ad UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^ae INSTITUT CURIE   (France)

^af INSTITUT CURIE   (France)

^ag UNIVERSITÉ PARIS DESCARTES   (France)

^ah GRENOBLE UNIVERSITY HOSPITAL   (France)

^ai UNIV GRENOBLE ALPES   (France)

^aj CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^ak HOSPICES CIVILS DE LYON   (France)

^al UNIVERSITY HOSPITAL OF BESANÇON   (France)

^am UNIVERSITÉ DE LORRAINE   (France)

^an CENTRE FRANÇOIS BACLESSE   (France)

^ao UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ap DANA FARBER CANCER INSTITUTE   (United States)

^aq HARVARD MEDICAL SCHOOL   (United States)

^ar BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^as CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^at Och Spine at New York Presbyterian Hospitals   (United States)

^au CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^av UNIVERSITY OF MELBOURNE   (Australia)

^aw MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ax Rigshospitalet   (Denmark)

^ay LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^az ROSWELL PARK CANCER INSTITUTE   (United States)

^ba AMERICAN CANCER SOCIETY   (United States)

^bb CENTRE HOSPITALIER DE CHAMBÉRY   (France)

^bc Australia and New Zealand Gynaecology Oncology Group   (Australia)

^bd OHIO STATE UNIVERSITY   (United States)

^be OHIO STATE UNIVERSITY   (United States)

^bf DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^bg WOMEN AND INFANTS HOSPITAL   (United States)

^bh NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^bi VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^bj N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^bk GEORGETOWN UNIVERSITY   (United States)

^bl VILNIUS UNIVERSITY   (Lithuania)

^bm State Research Institute Innovative Medicine Center   (Lithuania)

^bn UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^bo CEDARS SINAI MEDICAL CENTER   (United States)

^bp UNIVERSITY OF CALIFORNIA   (United States)

^bq UNIVERSITY OF CALIFORNIA   (United States)

^br UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^bs TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^bt UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^bu UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^bv UNIVERSITY OF MÜNSTER   (Germany)

^bw HANNOVER MEDICAL SCHOOL   (Germany)

^bx CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^by UNIVERSITY HOSPITAL ULM   (Germany)

^bz UNIVERSITY OF WÜRZBURG   (Germany)

^ca UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^cb UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^cc UNIVERSITY OF HELSINKI   (Finland)

^cd LAVAL UNIVERSITY   (Canada)

^ce UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^cf UNIVERSITY OF CHICAGO   (United States)

^cg BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^ch UNIVERSITY OF TORONTO   (Canada)

^ci MOUNT SINAI HOSPITAL   (Canada)

^cj UNIVERSITY OF TORONTO   (Canada)

^ck UNIVERSITY OF CALIFORNIA   (United States)

^cl MAYO CLINIC   (United States)

^cm NATIONAL CANCER INSTITUTE   (Italy)

^cn FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^co NATIONAL CANCER INSTITUTE   (United States)

^cp ODENSE UNIVERSITY HOSPITAL   (Denmark)

^cq AARHUS UNIVERSITY HOSPITAL   (Denmark)

^cr LILLEBAELT HOSPITAL   (Denmark)

^cs UNIVERSITY HOSPITAL OF PISA   (Italy)

^ct UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^cu LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^cv MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^cw RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^cx ERASMUS MEDICAL CENTER   (Netherlands)

^cy UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^cz Hereditary Breast and Ovarian Cancer Research Group Netherlands   (Netherlands)

^da TEL AVIV UNIVERSITY   (Israel)

^db STANFORD CANCER INSTITUTE   (United States)

^dc UNIVERSITY OF ICELAND   (Iceland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MULTICENTER STUDY; MUTATION; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; MUTATION; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84864821854     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0229     Document Type: Article

References (31)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30. (Pubitemid 36530000)
2. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998;62:676-89. (Pubitemid 28164626)
3. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, et al. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 1997;60:1079-84. (Pubitemid 27194092)
4. Vogl FD, Badzioch MD, Steele L, Neuhausen SL, Goldgar DE. Risks of cancer due to a single BRCA1 mutation in an extended Utah kindred. Fam Cancer 2007;6:63-71. (Pubitemid 46295300)
5. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer 2008;8:915-28.
6. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-89.
7. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001;8:197-209. (Pubitemid 32947642)
8. Jerome L, Shiry L, Leyland-Jones B. Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions. Endocr Relat Cancer 2003;10:561-78. (Pubitemid 38094891)
9. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-18. (Pubitemid 38868620)
10. Yee D, Morales FR, Hamilton TC, Von Hoff DD. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res 1991;51:5107-12.
11. Gallagher EJ, LeRoith D. Minireview: IGF, insulin, and cancer. Endocrinology 2011;152:2546-51.
12. Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, et al. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Res 2009;11:R76.
13. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE. An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 2007;9:104.
14. Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, Neuhausen SL, et al. RAD51 135G->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 2007;81:1186-200. (Pubitemid 350211449)
15. Barnes DR, Lee A, Investigators E, Investigators K, Easton DF, Anoniou AC. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol. 2012;36:274-91.
16. Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 1988;5:471-2.
17. Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. Proc Fifth Berkley Symp on Math Stat and Prob 1967;1:221-33.
18. Boos DD. On generalized score tests. Am Stat 1992;46:327-333.
19. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008;82:937-48.
20. Feigelson HS, Teras LR, Diver WR, Tang W, Patel AV, Stevens VL, et al. Genetic variation in candidate obesity genes ADRB2, ADRB3, GHRL, HSD11B1, IRS1, IRS2, and SHC1 and risk for breast cancer in the Cancer Prevention Study II. Breast Cancer Res 2008;10:R57.
21. Slattery ML, Sweeney C, Wolff R, Herrick J, Baumgartner K, Giuliano A, et al. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Breast Cancer Res Treat 2007;104:197-209. (Pubitemid 47084224)
22. Ioannidis A, Ikonomi E, Dimou NL, Douma L, Bagos PG. Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis. Mol Genet Metab 2010;99:174-83.
23. Mardilovich K, Pankratz SL, Shaw LM. Expression and function of the insulin receptor substrate proteins in cancer. Cell Commun Signal 2009;7:14.
24. Almind K, Inoue G, Pedersen O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 1996;97:2569-75.
25. Yoshimura R, Araki E, Ura S, Todaka M, Tsuruzoe K, Furukawa N, et al. Impact of natural IRS-1 mutations on insulin signals: mutations of IRS- 1 in the PTB domain and near SH2 protein binding sites result in impaired function at different steps of IRS-1 signaling. Diabetes 1997;46:929-36. (Pubitemid 27220990)
26. Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, et al. The Gly->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 2000;85:2004-13. (Pubitemid 32269313)
27. Hribal ML, Tornei F, Pujol A, Menghini R, Barcaroli D, Lauro D, et al. Transgenic mice overexpressing human G972R IRS-1 show impaired insulin action and insulin secretion. J Cell Mol Med 2008;12:2096-106.
28. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr 2007;86:s823-35.
29. Lee AV, Gooch JL, Oesterreich S, Guler RL, Yee D. Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 30-kinase inhibition. Mol Cell Biol 2000;20:1489-96. (Pubitemid 30100168)
30. Metz HE, Houghton AM. Insulin receptor substrate regulation of phosphoinositide 3-kinase. Clin Cancer Res 2011;17:206-11.
31. Shukla V, Coumoul X, Cao L, Wang RH, Xiao C, Xu X, et al. Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members. Cancer Res 2006;66:7151-7. (Pubitemid 44197693)